Baxter International Inc header image

Baxter International Inc

BAX

Equity

ISIN null / Valor 911702

New York Stock Exchange, Inc (2026-10-09)
USD 24.35+1.88%

Baxter International Inc
UMushroom community rating:

star star star star star
3.00 1 votes No rating yet
NegativeNeutralPositive

About company

Baxter International Inc is a global healthcare company that focuses on hospital, nutrition, renal, and surgical care. The company provides a range of products and services, including hemostatic agents, generic injectables, parenteral nutrition systems, and dialysis therapies. Baxter BioPharma Solutions, a contract manufacturing organization, has entered into agreements with leading companies to provide manufacturing services for COVID-19 vaccines and diagnostic tests. The company's recent acquisition of Hillrom has expanded its opportunities for innovation and access to care worldwide. Baxter is committed to transforming healthcare and advancing patient care from the hospital to the home, with a focus on improving outcomes for patients with chronic conditions such as end-stage renal disease.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

8.17%1Y
-33.3%3Y
-69.6%5Y

Performance

44.3%1Y
38.9%3Y
35.7%5Y

Volatility

Market cap

12589 M

Market cap (USD)

Daily traded volume (Shares)

3,011,408

Daily traded volume (Shares)

1 day high/low

29.06 / 28.34

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.00

1 votes
Performance:
starstarstarstarstar
2.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
2.00
Tobias Kurz
Switzerland, 30 Mar 2025
star star star star star
-

EQUITIES OF THE SAME SECTOR

CG Oncology Inc
CG Oncology Inc CG Oncology Inc Valor: 131996952
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.89%USD 63.82
Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.18%USD 19.45
Essity AB
Essity AB Essity AB Valor: 36851944
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.69%SEK 263.70
BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.48%USD 65.35
Agenus Inc
Agenus Inc Agenus Inc Valor: 134326284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.72%USD 7.67
Tempus AI Inc
Tempus AI Inc Tempus AI Inc Valor: 135855934
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.38%USD 70.93
Concentra Group Holdings Parent Inc
Concentra Group Holdings Parent Inc Concentra Group Holdings Parent Inc Valor: 136105334
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.58%USD 37.19
Lineage Inc
Lineage Inc Lineage Inc Valor: 136372357
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.03%USD 34.43
Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.15%USD 26.51
BioVersys AG
BioVersys AG BioVersys AG Valor: 21036264
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 26.50